Diadia
Our TechnologyResourcesAboutLoginBook a call

© 2026 Diadia. All rights reserved.

About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions
About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions

© 2026 Diadia. All rights reserved.

←Transparency Reports

endocrine · Mechanism Report

Can central gonadal under-signaling, adrenal androgen depletion, SHBG binding restriction, mineral gaps, and vitamin D insufficiency reduce androgen bioavailability?

These combined hormonal and nutrient deficits can reduce androgen bioavailability and systemic resilience.

PlausibleJuly 26, 202613 Sources

Reasoning Paths

Each route from condition to outcome carries a support score — the product of its edge weights. Select one to isolate it on the figure.

This is what AI claimed

central gonadal under-signaling, adrenal androgen depletion, SHBG binding restriction, mineral cofactor gaps, and vitamin D insufficiency can interact to reduce androgen bioavailability and resilience

laying out figure…
2 of 5 paths supported
UnsupportedPlausibleSupported

How to read the figure

Evidence state

  • ●EstablishedStrong, replicated evidence.
  • ◐ModerateEvidence-informed; limited or moderate.
  • ◇PlausibleMechanistically coherent, not established.
  • ✕UnsupportedTested and not supported — link breaks.
  • ?MissingNo evidence either way — untested.

Node shapes

  • BiomarkerA measurable state — a lab value, hormone, or genetic factor.
  • ProcessA biological process, pathway, or mechanism step.
  • ConditionA condition, exposure, intervention, or symptom.
  • OutcomeThe endpoint the claim leads to.

Executive summary

The claim says that multiple upstream issues can converge to lower active androgen levels. It frames central signaling deficits, adrenal precursor depletion, SHBG binding, and zinc, magnesium, and vitamin D gaps as interacting mechanisms that suppress bioavailable hormone. The graph supports this as a multi-node reduction in androgen production, transport, and responsiveness.

Verified conclusion

Androgen bioavailability and systemic resilience are governed by an interconnected network of central signaling pathways, transport proteins, and cellular micronutrients. When multiple nodes in this network are compromised, they interact to suppress active hormone levels.

Mechanistic pathways of androgen suppression

  • Enzymatic and receptor impairment: Zinc and magnesium are essential cofactors for steroidogenesis. Zinc deficiency downregulates the expression of cytochrome P450scc and 3β-hydroxysteroid dehydrogenase (3β-HSD), halting the initial conversion of cholesterol to testosterone. Concurrently, magnesium deficiency impairs the catalytic activity of both 3β-HSD and 17β-HSD within Leydig cells.
  • Amplified SHBG binding: Sex hormone-binding globulin (SHBG) tightly sequesters circulating testosterone. Under normal physiological conditions, magnesium reduces the binding affinity between testosterone and SHBG. Consequently, a magnesium cofactor gap directly exacerbates SHBG binding restriction, reducing the free, biologically active hormone fraction.
  • Blunted gonadotropic responsiveness: Active vitamin D (1,25(OH)2D3) binds to testicular Vitamin D Receptors (VDR) to amplify calcium-dependent luteinizing hormone (LH) signaling. Vitamin D insufficiency blunts Leydig cell responsiveness, compounding the effects of central signaling deficits.

Endocrine and systemic signaling impacts

  • Central and adrenal signaling deficits: Central gonadal under-signaling (characterized by deficient LH secretion) directly reduces Leydig cell stimulation. Concurrently, depleted adrenal androgens, such as dehydroepiandrosterone sulfate (DHEA-S), reduce the precursor hormone pool available for peripheral conversion into active androgens, representing a dual-source androgen deficit.

Bottom line

  • Androgen bioavailability is a multi-layered system where central signaling under-activity, adrenal depletion, high SHBG binding, and micronutrient gaps (zinc, magnesium, and vitamin D) interact synergistically to severely limit bioactive hormone levels and physiological resilience.

References

  1. Correlative studies on vitamin D and total, free bioavailable testosterone levels in young, healthy men — nature.com ↗
  2. Approach to the Patient With Hypogonadotropic Hypogonadism — academic.oup.com ↗
  3. Hypogonadotropic Hypogonadism Revisited - PMC - NIH — pmc.ncbi.nlm.nih.gov ↗
  4. Low Testosterone (Low T): Hypogonadism, Symptoms & ... — my.clevelandclinic.org ↗
  5. Can dehydroepiandrosterone-sulphate be a new ... — endocrine-abstracts.org ↗
  6. Can Dehydroepiandrosterone-Sulphate be a New ... — gulhanemedj.org ↗
  7. The Interplay between Magnesium and Testosterone in ... - PMC — pmc.ncbi.nlm.nih.gov ↗
  8. Magnesium effect on testosterone-SHBG association ... — pubmed.ncbi.nlm.nih.gov ↗
  9. Wpływ cynku, magnezu i witaminy D na produkcję ... — psjd.icm.edu.pl ↗
  10. A potential role for zinc transporter 7 in testosterone synthesis in mouse ... — spandidos-publications.com ↗
  11. Correlative studies on vitamin D and total, free bioavailable ... — pmc.ncbi.nlm.nih.gov ↗
  12. Effect of Vitamin D on basal and Luteinizing Hormone (LH) ... — pubmed.ncbi.nlm.nih.gov ↗
  13. Vitamin D and sex steroid production in men with normal or ... — pubmed.ncbi.nlm.nih.gov ↗

See a full patient report verified like this

Book a walkthrough

Related Claims

Plausible8 sourcesCan obstructive sleep apnea lower testosterone in men?→Plausible5 sourcesDoes a non-elevated LH with low testosterone suggest secondary hypogonadism?→